Claire Fabre Selected Research

Claire Fabre Research Topics

Disease

14	Neoplasms (Cancer) 11/2023 - 08/2004
7	Multiple Myeloma 08/2013 - 10/2010
4	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 09/2008 - 06/2007
3	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 09/2008 - 02/2008
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2023 - 02/2008
2	Uveal melanoma 05/2023 - 01/2020
2	Thrombocytopenia (Thrombopenia) 01/2022 - 01/2021
1	Colorectal Neoplasms (Colorectal Cancer) 11/2023
1	Renal Cell Carcinoma (Grawitz Tumor) 11/2023
1	Leukemia 03/2022
1	Liposarcoma 01/2022
1	Esophageal Squamous Cell Carcinoma 01/2022
1	Squamous Cell Carcinoma of Head and Neck 01/2022
1	Disease Progression 01/2022
1	Genomic Instability 01/2021
1	Osteosarcoma (Osteogenic Sarcoma) 01/2021
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 11/2014
1	Hematologic Neoplasms (Hematological Malignancy) 08/2013
1	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 12/2012
1	Polyploidy 06/2007
1	Starvation 11/2005
1	Lymphoma (Lymphomas) 08/2004

Drug/Important Bio-Agent (IBA)

5	Transcription Factors (Transcription Factor)IBA 01/2021 - 07/2008
4	siremadlinIBA 03/2022 - 01/2021
2	Drug CombinationsIBA 05/2023 - 01/2020
2	Antineoplastic Agents (Antineoplastics)IBA 01/2021 - 08/2013
2	Rituximab (Mabthera)FDA Link 11/2014 - 08/2004
2	Bortezomib (Velcade)FDA Link 12/2012 - 09/2012
1	NIS-793IBA 11/2023
1	spartalizumabIBA 11/2023
1	B7-H1 AntigenIBA 11/2023
1	Monoclonal AntibodiesIBA 11/2023
1	Cadherins (E-Cadherin)IBA 01/2022
1	ribociclibIBA 01/2022
1	CyclinsIBA 01/2022
1	Immunoconjugates (Immunoconjugate)IBA 01/2022
1	Biomarkers (Surrogate Marker)IBA 01/2021
1	Blocking AntibodiesIBA 01/2021
1	NVP-CGM097IBA 01/2021
1	Immune Checkpoint InhibitorsIBA 01/2021
1	AntigensIBA 01/2021
1	Growth Differentiation Factor 15IBA 01/2021
1	InterferonsIBA 12/2020
1	CLR457IBA 01/2019
1	Glucose (Dextrose)FDA LinkGeneric 01/2019
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 11/2014
1	dinaciclibIBA 11/2014
1	Histone Deacetylase InhibitorsIBA 08/2013
1	Immunoglobulins (Immunoglobulin)IBA 08/2013
1	DNA (Deoxyribonucleic Acid)IBA 01/2013
1	Proteasome InhibitorsIBA 12/2012
1	Proteasome Endopeptidase Complex (Proteasome)IBA 12/2012
1	PBS-1086IBA 09/2012
1	Proteins (Proteins, Gene)FDA Link 06/2012
1	Lenalidomide (CC 5013)FDA Link 10/2010
1	pomalidomideIBA 10/2010
1	CytokinesIBA 10/2010
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 02/2008
1	ErbB Receptors (EGF Receptor)IBA 02/2008
1	Caspase 3 (Caspase-3)IBA 06/2007
1	CaspasesIBA 06/2007
1	NF-kappa B (NF-kB)IBA 11/2005
1	PK 11195 (PK11195)IBA 11/2005
1	Sphingomyelin Phosphodiesterase (Sphingomyelinase)IBA 08/2004
1	AcidsIBA 08/2004

Therapy/Procedure

5	Therapeutics 05/2023 - 12/2012
2	Immunotherapy 01/2021 - 12/2020
1	Regimen B 01/2022
1	Stem Cell Transplantation 04/2012
1	Homologous Transplantation 04/2012
1	Drug Therapy (Chemotherapy) 08/2004